D. Smeenk

Morphologic characteristics of benign and malignant adrenocortical tumors

H. van Slooten, Aard Schaberg, D. Smeenk et al. · Cancer · 1985 · 329 citations · Full text

Adrenal Gland, Adrenal Cortex, Medicine +10

The treatment of adrenocortical carcinoma with o,p′-DDD: Prognostic simplications of serum level monitoring

H. van Slooten, A. J. Moolenaar, A.P. van Seter et al. · European Journal of Cancer and Clinical Oncology · 1984 · 196 citations

Adrenal Gland, Adrenocortical Carcinoma, Prognostic Simplications +5

Blood levels of o,p′-DDD following administration in various vehicles after a single dose and during long-term treatment

A. J. Moolenaar, H. van Slooten, Arnoud P. van Seters et al. · Cancer Chemotherapy and Pharmacology · 1981 · 71 citations

Hematology, Blood Levels, Single Dose +5

Circadian rhythms of urinary electrolyte excretion in freely moving rats

Ferdinand Roelfsema, D. van der Heide, D. Smeenk · Life Sciences · 1980 · 55 citations

Urology, Neurophysiology, Medicine +10

O,p′-DDD (Mitotane) levels in plasma and tissues during chemotherapy and at autopsy

H. van Slooten, Arnoud P. van Seters, D. Smeenk et al. · Cancer Chemotherapy and Pharmacology · 1982 · 41 citations

Medicine, Pharmacology, Pathology +6